Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0012115 | HP:0012115 | Hepatitis | 0 | ACP5 CL E G H | 54 | 124 | ORPHA:1855 | Spondyloenchondrodysplasia | HP:0040283 - Occasional | | | 16 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | AIRE CL E G H | 326 | 360 | OMIM:240300 | AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1 | | | | 92 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | AKR1D1 CL E G H | 6718 | 388 | ORPHA:79303 | Congenital bile acid synthesis defect type 2 | | | | 62 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | ALMS1 CL E G H | 7840 | 428 | ORPHA:64 | Alström syndrome | HP:0040283 - Occasional | | | 404 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | ALMS1 CL E G H | 7840 | 428 | OMIM:203800 | Alstrom syndrome | | | | 404 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | AMACR CL E G H | 23600 | 451 | OMIM:214950 | Bile acid synthesis defect, congenital, 4 | | | | 44 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | AMACR CL E G H | 23600 | 451 | ORPHA:79095 | Congenital bile acid synthesis defect type 4 | | | | 44 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | APC CL E G H | 324 | 583 | OMIM:114550 | Hepatocellular carcinoma | | | | 3179 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | ATP7A CL E G H | 538 | 869 | ORPHA:198 | Occipital horn syndrome | HP:0040282 - Frequent | | | 192 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | ATP7B CL E G H | 540 | 870 | ORPHA:905 | Wilson disease | HP:0040281 - Very frequent | | | 315 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | | | | 315 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | AXIN1 CL E G H | 8312 | 903 | OMIM:114550 | Hepatocellular carcinoma | | | | 3 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | BLNK CL E G H | 29760 | 14211 | ORPHA:33110 | Autosomal agammaglobulinemia | HP:0040283 - Occasional | | | 4 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | BTK CL E G H | 695 | 1133 | OMIM:300755 | Agammaglobulinemia, X-linked | | | | 109 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | BTK CL E G H | 695 | 1133 | OMIM:307200 | Isolated growth hormone deficiency, type III, with agammaglobulinemia | | | | 109 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | BTK CL E G H | 695 | 1133 | ORPHA:47 | X-linked agammaglobulinemia | HP:0040283 - Occasional | | | 109 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | C1S CL E G H | 716 | 1247 | OMIM:613783 | Complement component c1s deficiency | . | | | 7 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | C4B CL E G H | 721 | 1324 | OMIM:614379 | Complement component 4B deficiency | | | | 1 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CASP10 CL E G H | 843 | 1500 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 87 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CASP8 CL E G H | 841 | 1509 | OMIM:114550 | Hepatocellular carcinoma | | | | 37 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CD247 CL E G H | 919 | 1677 | ORPHA:169160 | T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta | HP:0040283 - Occasional | | | 8 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CD3D CL E G H | 915 | 1673 | ORPHA:169160 | T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta | HP:0040283 - Occasional | | | 18 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CD3E CL E G H | 916 | 1674 | ORPHA:169160 | T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta | HP:0040283 - Occasional | | | 24 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CD40LG CL E G H | 959 | 11935 | OMIM:308230 | Immunodeficiency, X-linked, with hyper-IgM | | | | 33 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CD79A CL E G H | 973 | 1698 | ORPHA:33110 | Autosomal agammaglobulinemia | HP:0040283 - Occasional | | | 9 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CD79B CL E G H | 974 | 1699 | ORPHA:33110 | Autosomal agammaglobulinemia | HP:0040283 - Occasional | | | 6 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CIITA CL E G H | 4261 | 7067 | OMIM:209920 | Bare lymphocyte syndrome, type II | | | | 118 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CIITA CL E G H | 4261 | 7067 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | | | | 118 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CLEC7A CL E G H | 64581 | 14558 | ORPHA:1334 | Chronic mucocutaneous candidiasis | HP:0040283 - Occasional | | | 3 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | COG6 CL E G H | 57511 | 18621 | ORPHA:363523 | Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome | HP:0040283 - Occasional | | | 71 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | COG8 CL E G H | 84342 | 18623 | OMIM:611182 | Congenital disorder of glycosylation, type IIh | | | | 39 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CTNNB1 CL E G H | 1499 | 2514 | OMIM:114550 | Hepatocellular carcinoma | | | | 88 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CYP7A1 CL E G H | 1581 | 2651 | ORPHA:209902 | Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | HP:0040281 - Very frequent | | | 11 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CYP7B1 CL E G H | 9420 | 2652 | OMIM:613812 | Bile acid synthesis defect, congenital, 3 | . | | | 57 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | FAS CL E G H | 355 | 11920 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 59 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | FASLG CL E G H | 356 | 11936 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 37 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | FOXP3 CL E G H | 50943 | 6106 | ORPHA:37042 | Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome | HP:0040283 - Occasional | | | 32 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | FOXP3 CL E G H | 50943 | 6106 | OMIM:304790 | Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked | | | | 32 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | GLIS3 CL E G H | 169792 | 28510 | OMIM:610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | . | | | 143 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:562 | McCune-Albright syndrome | HP:0040284 - Very rare | | | 101 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | GPR35 CL E G H | 2859 | 4492 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040283 - Occasional | | | 2 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | GUSB CL E G H | 2990 | 4696 | ORPHA:584 | Mucopolysaccharidosis type 7 | HP:0040282 - Frequent | | | 54 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231226 | Dominant beta-thalassemia | | | | 580 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | HSD3B7 CL E G H | 80270 | 18324 | OMIM:607765 | Bile acid synthesis defect, congenital, 1 | | | | 26 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IFIH1 CL E G H | 64135 | 18873 | OMIM:615846 | Aicardi-Goutieres syndrome 7 | | | | 28 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IGF2R CL E G H | 3482 | 5467 | OMIM:114550 | Hepatocellular carcinoma | | | | 4 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IGHG2 CL E G H | 3501 | 5526 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 1 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IGHM CL E G H | 3507 | 5541 | ORPHA:33110 | Autosomal agammaglobulinemia | HP:0040283 - Occasional | | | 7 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IGKC CL E G H | 3514 | 5716 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 5 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IGLL1 CL E G H | 3543 | 5870 | ORPHA:33110 | Autosomal agammaglobulinemia | HP:0040283 - Occasional | | | 3 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL12A CL E G H | 3592 | 5969 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL12RB1 CL E G H | 3594 | 5971 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | 46 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL17F CL E G H | 112744 | 16404 | ORPHA:1334 | Chronic mucocutaneous candidiasis | HP:0040283 - Occasional | | | 14 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL17RA CL E G H | 23765 | 5985 | ORPHA:1334 | Chronic mucocutaneous candidiasis | HP:0040283 - Occasional | | | 196 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL17RC CL E G H | 84818 | 18358 | ORPHA:1334 | Chronic mucocutaneous candidiasis | HP:0040283 - Occasional | | | 4 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL18BP CL E G H | 10068 | 5987 | OMIM:618549 | HEPATITIS, FULMINANT VIRAL, SUSCEPTIBILITY TO; FVH | | | | | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL21R CL E G H | 50615 | 6006 | OMIM:615207 | IMMUNODEFICIENCY 56; IMD56 | | | | 7 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IRF5 CL E G H | 3663 | 6120 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | 4 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | ITCH CL E G H | 83737 | 13890 | OMIM:613385 | AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD | | | | 3 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | ITCH CL E G H | 83737 | 13890 | ORPHA:228426 | Syndromic multisystem autoimmune disease due to Itch deficiency | HP:0040282 - Frequent | | | 3 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | KRT18 CL E G H | 3875 | 6430 | OMIM:215600 | Cirrhosis, familial | | | | 19 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | LRRC8A CL E G H | 56262 | 19027 | ORPHA:33110 | Autosomal agammaglobulinemia | HP:0040283 - Occasional | | | 3 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | MET CL E G H | 4233 | 7029 | OMIM:114550 | Hepatocellular carcinoma | | | | 375 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | MMEL1 CL E G H | 79258 | 14668 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | MST1 CL E G H | 4485 | 7380 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040283 - Occasional | | | 1 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | PDGFRL CL E G H | 5157 | 8805 | OMIM:114550 | Hepatocellular carcinoma | | | | 2 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | PGM1 CL E G H | 5236 | 8905 | OMIM:614921 | Congenital disorder of glycosylation, type It | . | | | 58 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | PI4KA CL E G H | 5297 | 8983 | ORPHA:436252 | Combined immunodeficiency-enteropathy spectrum | HP:0040284 - Very rare | | | 11 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | PIEZO1 CL E G H | 9780 | 28993 | OMIM:194380 | Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema | HP:0040283 - Occasional | | | 36 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | PIK3CA CL E G H | 5290 | 8975 | OMIM:114550 | Hepatocellular carcinoma | | | | 162 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | PIK3R1 CL E G H | 5295 | 8979 | ORPHA:33110 | Autosomal agammaglobulinemia | HP:0040283 - Occasional | | | 43 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | POU2AF1 CL E G H | 5450 | 9211 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | PRKCD CL E G H | 5580 | 9399 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 10 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | RASGRP1 CL E G H | 10125 | 9878 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | RFX5 CL E G H | 5993 | 9986 | OMIM:209920 | Bare lymphocyte syndrome, type II | | | | 38 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | RFX5 CL E G H | 5993 | 9986 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | | | | 38 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | RFXANK CL E G H | 8625 | 9987 | OMIM:209920 | Bare lymphocyte syndrome, type II | | | | 26 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | RFXANK CL E G H | 8625 | 9987 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | | | | 26 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | RFXAP CL E G H | 5994 | 9988 | OMIM:209920 | Bare lymphocyte syndrome, type II | | | | 34 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | RFXAP CL E G H | 5994 | 9988 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | | | | 34 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SEMA4D CL E G H | 10507 | 10732 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040283 - Occasional | | | | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SERPINA1 CL E G H | 5265 | 8941 | ORPHA:60 | Alpha-1-antitrypsin deficiency | HP:0040282 - Frequent | | | 131 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SH2D1A CL E G H | 4068 | 10820 | OMIM:308240 | Lymphoproliferative syndrome, X-linked, 1 | | | | 37 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SHPK CL E G H | 23729 | 1492 | ORPHA:440713 | Isolated sedoheptulokinase deficiency | HP:0040282 - Frequent | | | 2 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SKIC2 CL E G H | 6499 | 10898 | OMIM:614602 | Trichohepatoenteric syndrome 2 | . | | | | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SLC25A15 CL E G H | 10166 | 10985 | ORPHA:415 | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome | HP:0040282 - Frequent | | | 88 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SLC25A15 CL E G H | 10166 | 10985 | OMIM:238970 | Hyperornithinemia-Hyperammonemia-Homocitrullinuria syndrome | | | | 88 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SPIB CL E G H | 6689 | 11242 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | STAT1 CL E G H | 6772 | 11362 | ORPHA:391487 | Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome | HP:0040283 - Occasional | | | 89 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SYK CL E G H | 6850 | 11491 | OMIM:619381 | IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD82 | | | | 1 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TBX19 CL E G H | 9095 | 11596 | ORPHA:199296 | Congenital isolated ACTH deficiency | HP:0040283 - Occasional | | | 57 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TCF3 CL E G H | 6929 | 11633 | ORPHA:33110 | Autosomal agammaglobulinemia | HP:0040283 - Occasional | | | 2 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TCF4 CL E G H | 6925 | 11634 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040283 - Occasional | | | 241 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TNFSF15 CL E G H | 9966 | 11931 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TNPO3 CL E G H | 23534 | 17103 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | 71 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TOM1 CL E G H | 10043 | 11982 | ORPHA:391487 | Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome | HP:0040283 - Occasional | | | | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TP53 CL E G H | 7157 | 11998 | OMIM:114550 | Hepatocellular carcinoma | | | | 911 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TPP2 CL E G H | 7174 | 12016 | ORPHA:444463 | Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome | HP:0040281 - Very frequent | | | | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TRAF3IP2 CL E G H | 10758 | 1343 | ORPHA:1334 | Chronic mucocutaneous candidiasis | HP:0040283 - Occasional | | | 4 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TTC7A CL E G H | 57217 | 19750 | ORPHA:436252 | Combined immunodeficiency-enteropathy spectrum | HP:0040284 - Very rare | | | 26 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TTC7A CL E G H | 57217 | 19750 | OMIM:243150 | Gastrointestinal defects and immunodeficiency syndrome | | | | 26 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | VIPAS39 CL E G H | 63894 | 20347 | OMIM:613404 | Arthrogryposis, renal dysfunction, and cholestasis 2 | | | | 27 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | VPS33B CL E G H | 26276 | 12712 | OMIM:208085 | Arthrogryposis, renal dysfunction, and cholestasis 1 | | | | 63 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | XIAP CL E G H | 331 | 592 | OMIM:308240 | Lymphoproliferative syndrome, X-linked, 1 | | | | 81 | | |
HP:0012115 | HP:0012115 | Hepatitis | 0 | XIAP CL E G H | 331 | 592 | OMIM:300635 | Lymphoproliferative syndrome, X-linked, 2 | | | | 81 | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | AIRE CL E G H | 326 | 360 | OMIM:240300 | AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1 | | | | 92 | | |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | AKR1D1 CL E G H | 6718 | 388 | ORPHA:79303 | Congenital bile acid synthesis defect type 2 | | | | 62 | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | ALMS1 CL E G H | 7840 | 428 | OMIM:203800 | Alstrom syndrome | | | | 404 | | |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | AMACR CL E G H | 23600 | 451 | OMIM:214950 | Bile acid synthesis defect, congenital, 4 | . | | | 44 | | |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | AMACR CL E G H | 23600 | 451 | ORPHA:79095 | Congenital bile acid synthesis defect type 4 | | | | 44 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | APC CL E G H | 324 | 583 | OMIM:114550 | Hepatocellular carcinoma | | | | 3179 | | |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | . | | | 315 | | |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | ATP7B CL E G H | 540 | 870 | ORPHA:905 | Wilson disease | HP:0040281 - Very frequent | | | 315 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | AXIN1 CL E G H | 8312 | 903 | OMIM:114550 | Hepatocellular carcinoma | | | | 3 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | BTK CL E G H | 695 | 1133 | OMIM:300755 | Agammaglobulinemia, X-linked | | | | 109 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | BTK CL E G H | 695 | 1133 | OMIM:307200 | Isolated growth hormone deficiency, type III, with agammaglobulinemia | | | | 109 | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | C4B CL E G H | 721 | 1324 | OMIM:614379 | Complement component 4B deficiency | | | | 1 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | CASP8 CL E G H | 841 | 1509 | OMIM:114550 | Hepatocellular carcinoma | | | | 37 | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | CD40LG CL E G H | 959 | 11935 | OMIM:308230 | Immunodeficiency, X-linked, with hyper-IgM | . | | | 33 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | CIITA CL E G H | 4261 | 7067 | OMIM:209920 | Bare lymphocyte syndrome, type II | . | | | 118 | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | CIITA CL E G H | 4261 | 7067 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | | | | 118 | | |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | COG8 CL E G H | 84342 | 18623 | OMIM:611182 | Congenital disorder of glycosylation, type IIh | | | | 39 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | CTNNB1 CL E G H | 1499 | 2514 | OMIM:114550 | Hepatocellular carcinoma | | | | 88 | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:231226 | Dominant beta-thalassemia | HP:0040283 - Occasional | | | 580 | | |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | HSD3B7 CL E G H | 80270 | 18324 | OMIM:607765 | Bile acid synthesis defect, congenital, 1 | . | | | 26 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | IGF2R CL E G H | 3482 | 5467 | OMIM:114550 | Hepatocellular carcinoma | | | | 4 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | IGHG2 CL E G H | 3501 | 5526 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 1 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | IGKC CL E G H | 3514 | 5716 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 5 | | |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | IL18BP CL E G H | 10068 | 5987 | OMIM:618549 | HEPATITIS, FULMINANT VIRAL, SUSCEPTIBILITY TO; FVH | | | | | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | IL21R CL E G H | 50615 | 6006 | OMIM:615207 | IMMUNODEFICIENCY 56; IMD56 | | | | 7 | | |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | KRT18 CL E G H | 3875 | 6430 | OMIM:215600 | Cirrhosis, familial | | | | 19 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | MET CL E G H | 4233 | 7029 | OMIM:114550 | Hepatocellular carcinoma | | | | 375 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | PDGFRL CL E G H | 5157 | 8805 | OMIM:114550 | Hepatocellular carcinoma | | | | 2 | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | PGM1 CL E G H | 5236 | 8905 | OMIM:614921 | Congenital disorder of glycosylation, type It | | | | 58 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | PIK3CA CL E G H | 5290 | 8975 | OMIM:114550 | Hepatocellular carcinoma | | | | 162 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | RFX5 CL E G H | 5993 | 9986 | OMIM:209920 | Bare lymphocyte syndrome, type II | . | | | 38 | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | RFX5 CL E G H | 5993 | 9986 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | | | | 38 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | RFXANK CL E G H | 8625 | 9987 | OMIM:209920 | Bare lymphocyte syndrome, type II | . | | | 26 | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | RFXANK CL E G H | 8625 | 9987 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | | | | 26 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | RFXAP CL E G H | 5994 | 9988 | OMIM:209920 | Bare lymphocyte syndrome, type II | . | | | 34 | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | RFXAP CL E G H | 5994 | 9988 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | | | | 34 | | |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | SH2D1A CL E G H | 4068 | 10820 | OMIM:308240 | Lymphoproliferative syndrome, X-linked, 1 | | | | 37 | | |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | SKIC2 CL E G H | 6499 | 10898 | OMIM:614602 | Trichohepatoenteric syndrome 2 | | | | | | |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | SLC25A15 CL E G H | 10166 | 10985 | OMIM:238970 | Hyperornithinemia-Hyperammonemia-Homocitrullinuria syndrome | . | | | 88 | | |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | TP53 CL E G H | 7157 | 11998 | OMIM:114550 | Hepatocellular carcinoma | | | | 911 | | |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | TTC7A CL E G H | 57217 | 19750 | OMIM:243150 | Gastrointestinal defects and immunodeficiency syndrome | HP:0040283 - Occasional | | | 26 | | |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | VIPAS39 CL E G H | 63894 | 20347 | OMIM:613404 | Arthrogryposis, renal dysfunction, and cholestasis 2 | . | | | 27 | | |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | VPS33B CL E G H | 26276 | 12712 | OMIM:208085 | Arthrogryposis, renal dysfunction, and cholestasis 1 | . | | | 63 | | |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | XIAP CL E G H | 331 | 592 | OMIM:308240 | Lymphoproliferative syndrome, X-linked, 1 | | | | 81 | | |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | AIRE CL E G H | 326 | 360 | OMIM:240300 | AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1 | | | | 92 | | |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | ALMS1 CL E G H | 7840 | 428 | OMIM:203800 | Alstrom syndrome | . | | | 404 | | |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | APC CL E G H | 324 | 583 | OMIM:114550 | Hepatocellular carcinoma | . | | | 3179 | | |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | AXIN1 CL E G H | 8312 | 903 | OMIM:114550 | Hepatocellular carcinoma | . | | | 3 | | |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | BTK CL E G H | 695 | 1133 | OMIM:300755 | Agammaglobulinemia, X-linked | . | | | 109 | | |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | BTK CL E G H | 695 | 1133 | OMIM:307200 | Isolated growth hormone deficiency, type III, with agammaglobulinemia | . | | | 109 | | |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | C4B CL E G H | 721 | 1324 | OMIM:614379 | Complement component 4B deficiency | . | | | 1 | | |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | CASP8 CL E G H | 841 | 1509 | OMIM:114550 | Hepatocellular carcinoma | . | | | 37 | | |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | CIITA CL E G H | 4261 | 7067 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | HP:0040282 - Frequent | | | 118 | | |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | CTNNB1 CL E G H | 1499 | 2514 | OMIM:114550 | Hepatocellular carcinoma | . | | | 88 | | |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | IGF2R CL E G H | 3482 | 5467 | OMIM:114550 | Hepatocellular carcinoma | . | | | 4 | | |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | IL21R CL E G H | 50615 | 6006 | OMIM:615207 | IMMUNODEFICIENCY 56; IMD56 | | | | 7 | | |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | MET CL E G H | 4233 | 7029 | OMIM:114550 | Hepatocellular carcinoma | . | | | 375 | | |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | PDGFRL CL E G H | 5157 | 8805 | OMIM:114550 | Hepatocellular carcinoma | . | | | 2 | | |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | PIK3CA CL E G H | 5290 | 8975 | OMIM:114550 | Hepatocellular carcinoma | . | | | 162 | | |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | RFX5 CL E G H | 5993 | 9986 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | HP:0040282 - Frequent | | | 38 | | |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | RFXANK CL E G H | 8625 | 9987 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | HP:0040282 - Frequent | | | 26 | | |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | RFXAP CL E G H | 5994 | 9988 | ORPHA:572 | Immunodeficiency by defective expression of MHC class II | HP:0040282 - Frequent | | | 34 | | |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | TP53 CL E G H | 7157 | 11998 | OMIM:114550 | Hepatocellular carcinoma | . | | | 911 | | |